Bioventus (BVS) Retained Earnings (2021 - 2026)

Bioventus (BVS) has reported Retained Earnings for 6 consecutive years, with $527.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Retained Earnings rose 2.56% year-over-year to $527.9 million; the trailing twelve-month figure through Jun 2026 stood at $527.9 million (up 2.56% YoY), and the FY2025 full-year result was $520.9 million, up 2.51% from the prior year.
• Retained Earnings climbed to $527.9 million in Q2 2026 per BVS's latest filing, from $522.9 million in the prior quarter.
• Across five years, Retained Earnings topped out at $527.9 million in Q2 2026 and bottomed at $467.9 million in Q2 2022.
• Historically, Retained Earnings has averaged $500.2 million across 5 years, with a median of $499.0 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Retained Earnings soared 227.41% in 2022, then grew 0.75% in 2023.
• Over 5 years, Retained Earnings stood at $490.6 million in 2022, then advanced by 0.75% to $494.3 million in 2023, then increased by 2.8% to $508.1 million in 2024, then climbed by 2.51% to $520.9 million in 2025, then increased by 1.36% to $527.9 million in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered $527.9 million, $522.9 million, and $520.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.